162 related articles for article (PubMed ID: 11173544)
1. Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer.
Matsumoto M; Takeda Y; Maki H; Hojo K; Wada T; Nishitani Y; Maekawa R; Yoshioka T
Jpn J Cancer Res; 2001 Jan; 92(1):51-8. PubMed ID: 11173544
[TBL] [Abstract][Full Text] [Related]
2. Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.
Takeda Y; Wada T; Nishitani Y; Matsumoto M; Hojo K; Maekawa R; Yoshioka T
Cancer Lett; 2002 Aug; 182(1):61-8. PubMed ID: 12175524
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
Uchida N; Yamada H; Maekawa R; Yoshioka T
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1943-9. PubMed ID: 12465394
[TBL] [Abstract][Full Text] [Related]
4. Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel.
Yamada H; Uchida N; Maekawa R; Yoshioka T
Cancer Lett; 2001 Oct; 172(1):17-25. PubMed ID: 11595125
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.
Uchida N; Takeda Y; Kasai H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1998; 18(5A):3375-9. PubMed ID: 9858911
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].
Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of combined nedaplatin and docetaxel therapy for human head and neck cancer in vivo.
Yamada H; Maki H; Takeda Y; Orita S
Anticancer Res; 2006; 26(2A):989-94. PubMed ID: 16619497
[TBL] [Abstract][Full Text] [Related]
8. [Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].
Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
Gan To Kagaku Ryoho; 1998 Jan; 25(1):79-87. PubMed ID: 9464333
[TBL] [Abstract][Full Text] [Related]
9. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.
Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1998; 18(1A):247-52. PubMed ID: 9568085
[TBL] [Abstract][Full Text] [Related]
10. Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.
Bajetta E; Stani SC; De Candis D; Zaffaroni N; Zilembo N; Cortinovis D; Aglione S; Mariani L; Formisano B; Bidoli P
Ann Oncol; 2003 Feb; 14(2):242-7. PubMed ID: 12562651
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
Grigorescu AC; Draghici IN; Nitipir C; Gutulescu N; Corlan E
Lung Cancer; 2002 Jul; 37(1):9-14. PubMed ID: 12057861
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.
Uchida N; Yoshida H; Yamada H; Wada T; Daikatsu K; Ikeuchi I; Maekawa R; Sugita K; Yoshioka T
Jpn J Cancer Res; 1999 Aug; 90(8):887-94. PubMed ID: 10543262
[TBL] [Abstract][Full Text] [Related]
14. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
Uchida N; Takeda Y; Kasai H; Hojo K; Wada T; Nishida K; Maekawa R; Sugita K; Yoshioka T
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2267-74. PubMed ID: 9881084
[TBL] [Abstract][Full Text] [Related]
15. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
Zhang R; Ru Y; Gao Y; Li J; Mao S
Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
[TBL] [Abstract][Full Text] [Related]
16. Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.
Uchida N; Takeda Y; Hojo K; Maekawa R; Sugita K; Yoshioka T
Eur J Cancer; 1998 Oct; 34(11):1796-801. PubMed ID: 9893671
[TBL] [Abstract][Full Text] [Related]
17. Randomized control study of nedaplatin or cisplatin concomitant with other chemotherapy in the treatment of advanced non-small cell lung cancer.
Li CH; Liu MY; Liu W; Li DD; Cai L
Asian Pac J Cancer Prev; 2014; 15(2):731-6. PubMed ID: 24568487
[TBL] [Abstract][Full Text] [Related]
18. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
Lord RV; Brabender J; Gandara D; Alberola V; Camps C; Domine M; Cardenal F; Sánchez JM; Gumerlock PH; Tarón M; Sánchez JJ; Danenberg KD; Danenberg PV; Rosell R
Clin Cancer Res; 2002 Jul; 8(7):2286-91. PubMed ID: 12114432
[TBL] [Abstract][Full Text] [Related]
19. Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801.
Takayama K; Takeshita M; Inoue K; Ichiki M; Fujita M; Harada T; Shiraishi Y; Wataya H; Tokunaga S; Yamada T; Uchino J; Sugio K
Oncologist; 2020 Aug; 25(8):e1146-e1157. PubMed ID: 32385918
[TBL] [Abstract][Full Text] [Related]
20. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
Zhang P; Feng FY; Wu LY; Hu Y; Liu JW; Gao YJ; Guan XQ; Nan KJ; Suo AL; Wang XW; Zhang MH; Zhang WD; Li CW; Zhang Y; Zhao JB
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
